Oncopeptides AB: Oncopeptides completes patient enrollment in phase 2 PORT study (Cision)

Press/Media

Period	5 May 2021

Media coverage

Title	Oncopeptides AB: Oncopeptides completes patient enrollment in phase 2 PORT study (Cision)
Media name/outlet	Avanza Bank AB
Country/Territory	Sweden
Date	5/05/21
URL	https://www.avanza.se/placera/pressmeddelanden/2021/05/05/oncopeptides-ab-oncopeptides-completes-patient-enrollment-in-phase-2-port-study.html
Persons	Joshua Richter